Category: Smith & Nephew
Here's a look at some of the top legal news stories for medical device companies this week: PAD: Shockwave Medical raises $40M; PAD: Intact Vascular raises $39m for Tack device; ConvaTec plans $1.9B refi; Outset Medical raises $60m for home dialysis device; Smith & Nephew gets in on OrthoSpace round
Smith & Nephew joins a funding round for Israel-based OrthoSpace and its InSpace rotator cuff-treating balloon system.
Here's a look at some of the top regulatory stories for medical device companies this week: FDA withdraws older guidance documents; Medtech panel: Good news-bad news on FDA, value-based healthcare; Medtronic launches new spine devices; FDA warns Smith & Nephew on Truclear Ultra morcellator; FDA clears Medtronic's Euphora balloon
The FDA sends a warning letter to Smith & Nephew after inspections turn up problems with a version of its Truclear Ultra laparoscopic power morcellator.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Smith & Nephew 'working hard' on acquisitions trail, CEO says; Profound Medical goes public in reverse merger; Greatbatch mulls spinout for Algostim SCS business; Wright Medical delays Augment timeline; St. Jude Medical closes Spinal Modulation buy
Smith & Nephew buys a pair of software assets to bolster its Syncera repless sales business.
Smith & Nephew (NYSE:SNN) added a pair of software assets to its Syncera generic sales business, a so-called "repless" model for orthopedic devices.
Smith & Nephew CEO Olivier Bohuon says the company is 'working hard' on the acquisitions trail, looking to expand its emerging markets footprint and evaluating early-stage bolt-ons.